Compounds and method for reducing uric acid

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9115072
APP PUB NO 20130259850A1
SERIAL NO

13890789

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I or a pharmaceutically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMA CINQ LLC1601 RESEARCH BOULEVARD ROCKVILLE MD 20850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arudchandran, Ramachandran Germantown, US 6 16
Bamat, Michael K Potomac, US 37 427
O'Neil, James Dennen Frederick, US 6 17
Sharma, Shalini Gaithersburg, US 65 678
von, Borstel Reid W Potomac, US 110 1215

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00